307 related articles for article (PubMed ID: 22987055)
1. The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes.
Martin JF; Kristensen SD; Mathur A; Grove EL; Choudry FA
Nat Rev Cardiol; 2012 Nov; 9(11):658-70. PubMed ID: 22987055
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytes and platelets in vascular disease.
van der Loo B; Martin JF
Baillieres Clin Haematol; 1997 Feb; 10(1):109-23. PubMed ID: 9154318
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocyte modification of platelets in thrombocytopenia.
Roweth HG; Parvin S; Machlus KR
Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
[TBL] [Abstract][Full Text] [Related]
4. A role for changes in platelet production in the cause of acute coronary syndromes.
van der Loo B; Martin JF
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):672-9. PubMed ID: 10073972
[TBL] [Abstract][Full Text] [Related]
5. Immature platelets in patients with acute coronary syndromes.
Grove EL; Hvas AM; Kristensen SD
Thromb Haemost; 2009 Jan; 101(1):151-6. PubMed ID: 19132202
[TBL] [Abstract][Full Text] [Related]
6. Immature Platelets: Clinical Relevance and Research Perspectives.
Lev EI
Circulation; 2016 Oct; 134(14):987-988. PubMed ID: 27698048
[No Abstract] [Full Text] [Related]
7. The control of megakaryocyte ploidy and platelet production: biology and pathology.
Gladwin AM; Martin JF
Int J Cell Cloning; 1990 Jul; 8(4):291-8. PubMed ID: 2205666
[TBL] [Abstract][Full Text] [Related]
8. Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes.
Verdoia M; Sartori C; Pergolini P; Nardin M; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
J Thromb Thrombolysis; 2016 May; 41(4):663-70. PubMed ID: 26370198
[TBL] [Abstract][Full Text] [Related]
9. The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis.
Kristensen SD
Dan Med Bull; 1992 Apr; 39(2):110-27. PubMed ID: 1611918
[TBL] [Abstract][Full Text] [Related]
10. Megakaryopoiesis and Platelet Biology: Roles of Transcription Factors and Emerging Clinical Implications.
Noh JY
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502524
[TBL] [Abstract][Full Text] [Related]
11. Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of CD34+ cells in the ischaemic microcirculation.
Stellos K; Bigalke B; Borst O; Pfaff F; Elskamp A; Sachsenmaier S; Zachmann R; Stamatelopoulos K; Schönberger T; Geisler T; Langer H; Gawaz M
Eur Heart J; 2013 Aug; 34(32):2548-56. PubMed ID: 23594593
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale.
Wang Y; Hayes V; Jarocha D; Sim X; Harper DC; Fuentes R; Sullivan SK; Gadue P; Chou ST; Torok-Storb BJ; Marks MS; French DL; Poncz M
Blood; 2015 Jun; 125(23):3627-36. PubMed ID: 25852052
[TBL] [Abstract][Full Text] [Related]
13. Relation between ticagrelor response and levels of circulating reticulated platelets in patients with non-ST elevation acute coronary syndromes.
Vaduganathan M; Zemer-Wassercug N; Rechavia E; Lerman-Shivek H; Perl L; Leshem-Lev D; Orvin K; Kornowski R; Lev EI
J Thromb Thrombolysis; 2015 Aug; 40(2):211-7. PubMed ID: 25631351
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9 expression and activation in acute coronary syndrome patients on dual anti-platelet therapy.
Hally KE; La Flamme AC; Larsen PD; Harding SA
Thromb Res; 2016 Dec; 148():89-95. PubMed ID: 27815972
[TBL] [Abstract][Full Text] [Related]
15. Role of mean platelet volume in triagging acute coronary syndromes.
Yilmaz MB; Cihan G; Guray Y; Guray U; Kisacik HL; Sasmaz H; Korkmaz S
J Thromb Thrombolysis; 2008 Aug; 26(1):49-54. PubMed ID: 17705053
[TBL] [Abstract][Full Text] [Related]
16. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes.
Aksu H; Ozer O; Unal H; Hobikoglu G; Norgaz T; Buturak A; Soylu O; Narin A
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):686-93. PubMed ID: 19730245
[TBL] [Abstract][Full Text] [Related]
17. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome.
Huang HL; Chen CH; Kung CT; Li YC; Sung PH; You HL; Lin YH; Huang WT
Biomed J; 2019 Apr; 42(2):107-115. PubMed ID: 31130246
[TBL] [Abstract][Full Text] [Related]
19. Platelet heterogeneity and coronary artery thrombosis.
Kristensen SD; Martin JF
Platelets; 1991; 2(1):11-7. PubMed ID: 21043956
[TBL] [Abstract][Full Text] [Related]
20. Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
Chatterjee M; Behrendt A; Schmid M; Beck S; Schneider M; Mack A; Müller I; Geisler T; Gawaz M
Thromb Haemost; 2017 Jan; 117(2):311-324. PubMed ID: 27929199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
